Paracetamol 10 mg per ml infusion in 100 ml bottle,Povidone iodine oint 10 percent of 5 percent 20
Indian Army
Bid Publish Date
19-Feb-2026, 11:03 am
Bid End Date
06-Mar-2026, 11:00 am
Location
Progress
Quantity
17009
Category
HYOSCINE BUTYLBROMIDE INJECTION 20MG ML
Bid Type
Two Packet Bid
The Organization is the Indian Army under the Department Of Military Affairs seeking procurement across 12 items in the pharmaceutical and ocular care category, including HYOSCINE BUTYLBROMIDE INJECTION 20MG/ML, OLMESARTAN 20MG PLUS HYDROCHLOROTHIAZIDE 12.5MG TAB, SODIUM CHLORIDE 5% EYE DROPS, SODIUM CHROMOGLYCATE 2% EYE DROPS, SODIUM VALPROATE + VALPROIC ACID 200 MG TAB, INJ TRANEXAMIC ACID, INJ ZOLEDRONIC ACID 4 MG, ISOTRETINOIN 10 MG & 20 MG TAB, KETOROLAC 0.4% EYE DROPS, LEVETIRACETAM SR 500 MG TAB, and LEVOCARNITINE 1 GM INJECTION.
The procurement value is not disclosed; the order scope spans 12 items with medical and ophthalmic formulations, intended for military medical usage and supply continuity. The tender emphasizes quantity adjustment rights and extended delivery timing through an option clause. This purchase targets reliable medical-grade products meeting standard clinic requirements and implies strict supplier eligibility for pharmaceutical distribution to defense units.
Key differentiators include the option to increase/decrease quantities by up to 25% at contract at contracted rates and a delivery-time calculation methodology tied to original delivery periods. The BOQ lists 12 items but provides no itemized quantities, suggesting a flexible, supply-chain-focused tender intended to secure essential medicines and ocular therapies.
There are no explicit technical specifications documented in the data. Available details indicate a broad product mix: injections, tablets, and ophthalmic solutions across several active ingredients. The absence of explicit IS/ISO standards or packaging specifications means bidders must rely on standard pharmaceutical licensing, GMP/compliance, and defense procurement registration. The ATC/ATC-like terms are referenced in a separate uploaded document. Bidders should prepare for standard defense supplier qualifications and batch-level traceability documentation. Expected submission likely requires GMP-compliant manufacturing or authorized distribution channels, with clear shelf-life and cold-chain controls where applicable.
HYOSCINE BUTYLBROMIDE INJECTION 20MG/ML
OLMESARTAN 20MG + HYDROCHLOROTHIAZIDE 12.5MG TAB
SODIUM CHLORIDE 5% EYE DROPS
SODIUM CHROMOGLYCATE 2% EYE DROPS
SODIUM VALPROATE + VALPROIC ACID 200 MG TAB
INJ TRANEXAMIC ACID
INJ ZOLEDRONIC ACID 4 MG
ISOTRETINOIN 10 MG & 20 MG TAB
KETOROLAC 0.4% EYE DROPS
LEVETIRACETAM SR 500 MG TAB
LEVOCARNITINE 1 GM INJECTION
Quantity adjustment up to 25% at contract; extended delivery time rules apply
Delivery period starts after last date of original delivery order
Final ATC document will specify EMD, delivery, and payment terms
BOQ contains 12 items with no explicit quantities
Bi-annual or annual procurement norms probable for defense medical supplies
Not specified in provided data; verify with ATC; likely milestone-based or against delivery
Delivery period starts after the last date of original delivery order; option clause allows extended time with minimum 30 days
Details not provided; confirm LD/penalties in ATC and contract terms
GMP/GDP-compliant pharmaceutical supplier or authorized distributor
Defense procurement registration or eligibility for government contracts
Evidence of prior medical/pharmaceutical supply experience to large organizations
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
Indian Army
HYDERABAD, TELANGANA
Indian Army
HYDERABAD, TELANGANA
Indian Army
Indian Air Force
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | HYOSCINE BUTYLBROMIDE INJECTION 20MG ML | HYOSCINE BUTYLBROMIDE INJECTION 20MG/ML | 18 | no | [email protected] | 15 |
| 2 | OLMESARTAN 20MG PLUS HYDROCHLOROTHIAZIDE 12 POINT 5MG TAB | OLMESARTAN 20MG + HYDROCHLOROTHIAZIDE 12.5 MG TAB | 1,200 | no | [email protected] | 15 |
| 3 | SODIUM CHLORIDE 5 PERCENT EYE DROPS | SODIUM CHLORIDE 5% EYE DROPS (E/D) | 105 | no | [email protected] | 15 |
| 4 | SODIUM CHROMOGLYCATE 2 PERCENT BOTT OF 10 ML EYE DROPS | SODIUM CHROMOGLYCATE 2% BOTT OF 10 ML EYE DROPS (CROMAL E/D) | 60 | no | [email protected] | 15 |
| 5 | SODIUM VALPROATE PLUS VALPROIC ACID 200 MG TAB | SODIUM VALPROATE + VALPROIC ACID 200 MG TAB | 1,200 | no | [email protected] | 15 |
| 6 | INJ TRANEXAMIC ACID | INJ TRANEXAMIC ACID | 5 | no | [email protected] | 15 |
| 7 | INJ ZOLEDRONIC ACID 4 MG | INJ ZOLEDRONIC ACID 4 MG | 21 | vial | [email protected] | 15 |
| 8 | ISOTRETINOIN 10 MG TAB | ISOTRETINOIN 10 MG TAB | 6,600 | no | [email protected] | 15 |
| 9 | ISOTRETINOIN 20 MG TAB | ISOTRETINOIN 20 MG TAB | 2,100 | no | [email protected] | 15 |
| 10 | KETOROLAC 0 point 4 percent E D | KETOROLAC 0.4% E/D | 120 | no | [email protected] | 15 |
| 11 | LEVETIRACETAM SR 500 MG TAB | LEVETIRACETAM SR 500 MG TAB | 3,600 | no | [email protected] | 15 |
| 12 | LEVOCARNITINE 1 GM INJECTION | LEVOCARNITINE 1 GM INJECTION | 1,980 | no | [email protected] | 15 |
Discover companies most likely to bid on this tender
GST certificate
PAN card
Experience certificates (previous defense/pharma supply)
Financial statements (last 2-3 years)
EMD/Security deposit as per ATC
Technical bid documents
OEM authorizations (for generic/brand-specific items)
GMP/cGMP certification where applicable
Drug distribution licenses and product registrations
Quality/compliance certificates per item category
Key insights about DELHI tender market
Bidders must submit GST, PAN, experience certificates, financial statements, EMD, and technical compliance documents as per the ATC. Ensure GMP/GDP licenses, OEM authorizations, and defense procurement registration. Delivery terms may include a 25% quantity option; verify all packaging and shelf-life requirements in the ATC.
Required documents typically include GST certificate, PAN, experience certificates, financial statements, EMD, technical bid, OEM authorization, GMP certificates, and product registrations. The ATC will specify formats, signatories, and submission portals for the 12-item schedule.
Delivery terms allow up to 25% quantity variation at contract and during currency. Delivery starts from the last date of the original order; additional time equals (increased quantity/original quantity) times original days, minimum 30 days. Confirm exact dates in the ATC.
The items include HYOSCINE BUTYLBROMIDE INJECTION, OLMESARTAN 20MG + HYDROCHLOROTHIAZIDE 12.5MG TAB, SODIUM CHLORIDE 5% EYE DROPS, SODIUM CHROMOGLYCATE 2% EYE DROPS, SODIUM VALPROATE + VALPROIC ACID 200 MG TAB, TRANEXAMIC ACID INJECTION, ZOLEDRONIC ACID 4 MG INJECTION, ISOTRETINOIN 10/20 MG TABS, KETOROLAC 0.4% EYE DROPS, LEVETIRACETAM SR 500 MG TAB, LEVOCARNITINE 1 GM INJECTION, among others.
Bidders should anticipate GMP/GDP compliance, drug registrations, and OEM authorizations. While ISI/ISO standards are not specified in the data, defense tenders typically require traceability, batch-wise certification, expiry tracking, and regulatory approvals for each product line.
The ATC specifies delivery timing rules tied to the original order; there is an option-based extension with minimum 30 days. Payment terms are not disclosed in the data; bidders must confirm terms in the ATC and follow standard defense payment procedures.
The BOQ lists 12 items but provides no explicit quantities. Bidders should prepare flexible pricing for multiple-package lots and be ready for quantity adjustments within 25% at order placement and during contract execution per the option clause.
Show prior experience supplying to large institutions, provide GMP/GDP licenses, active drug registrations, and OEM authorizations. Include financial strength documents and supply-chain evidence, ensuring compliance with defense procurement norms and regulatory requirements.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS